Browse Studies — Arctuva

Phase 1

Channeling Hope Trial 1: A Phase 1, Open-label, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) of Chronic Aprepitant Use in Individuals With Congenital Contractures of the Limbs and Face, Hypotonia, and Development Delay (CLIFAHDD)

There are no drug treatments for individuals with Congenital Contractures of the Limb and Face, Hypotonia, and Developmental Delay (CLIFAHDD), an ultra-rare an…

CLIFAHDDCongenital Contractures of the Limbs and Face, Hypotonia, and Developmental DelayNALCN Channelopathy+2 more

Estimated

~$10 – $6,250

Find your next paid study

Channeling Hope Trial 1: A Phase 1, Open-label, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) of Chronic Aprepitant Use in Individuals With Congenital Contractures of the Limbs and Face, Hypotonia, and Development Delay (CLIFAHDD)

Neurogenetic Disorders: A Longitudinal Study on Natural History and Intervention Strategies